Press Release June 16, 2023 Beta Thalassemia Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Novartis, Hoffmann-La Roche, Vertex Pharma, Bristol-Myers Squibb, Sanofi, HemaQues
Press Release June 16, 2023 Obstructive Sleep Apnea Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Takeda, Bayer, Apnimed, Desitin Arzneimittel GmbH, Eli Lilly, Jazz Pharma
Press Release June 16, 2023 Glioblastoma Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Curtana Pharmaceuticals, Prelude Therapeutics, OX2 Therapeutics
Press Release June 16, 2023 Neurofibromatosis Type-2 Pipeline, Clinical Trials, and Emerging Drugs (2023) | Companies – AstraZeneca, Recursion Pharma, Betta Pharma, Novartis Pharma, Genentech, Takeda, and others
Press Release June 16, 2023 Septic Shock Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | AstraZeneca, Eli Lilly and Company, La Jolla Pharma, Vivacelle Bio
Press Release June 16, 2023 Netherton Syndrome Pipeline, NDA Approvals, Emerging Drugs and Clinical Trials (2023) | Companies – Novartis, Timber Pharma, Bridge Biopharma, Evotec AG, Dermelix Biotherapeutics, Krystal Biotech.
Press Release June 16, 2023 Sciatica Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Regeneron, Medtronic, Cephalon, Biogen, Johnson & Johnson
Press Release June 16, 2023 Neuroendocrine Tumors Pipeline, Clinical Trials, and Emerging Drugs (2023) | Companies – MedImmune, Genentech, Merck & Co, Pfizer, Takeda Oncology, Hutchison MediPharma, and Others
Press Release June 16, 2023 Neuroblastoma Pipeline, NDA Approvals, Emerging Drugs, and Clinical Trials (2023) | Companies – Clarity Pharmaceuticals, Y mAbs Therapeutics, Nova Biopharma, Eli Lilly and Company, GE Healthcare